Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation

Biomolecules. 2022 Jul 1;12(7):924. doi: 10.3390/biom12070924.

Abstract

With the continuous advances in molecular biotechnology, many new cell death methods have been discovered. Pyroptosis is a programmed cell death process that differs from apoptosis and autophagy in cell morphology and function. Compared with apoptosis and autophagy, pyroptosis is primarily mediated by intracellular inflammasome and gasdermin D of the gasdermin protein family and involves the release of numerous inflammatory factors. Pyroptosis has been found to be involved in the occurrence and development of infectious diseases and other diseases involving the nervous system and the cardiovascular system. Recent studies have also reported the occurrence of pyroptosis in tumor cells. Accordingly, exploring its effect on tumors has become one of the research hotspots. Herein, recent research progress on pyroptosis is reviewed, especially its role in the development of gynecological tumors. As the pathogenesis of gynecological tumor is better understood, new targets have been introduced for the prevention and clinical treatment of gynecological tumors.

Keywords: cervical cancer; endometrial carcinoma; ovarian cancer; pyroptosis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Death
  • Female
  • Genital Neoplasms, Female* / therapy
  • Humans
  • Inflammasomes / metabolism
  • Pyroptosis*

Substances

  • Inflammasomes

Grants and funding

The study was supported by the The First Hospital of Lanzhou University Foundation (No. ldyyyn2019-62); the Regional Scientists Fund of the National Natural Science Foundation of China (No. 81960275); Gansu Provincial Department of Science and Technology Foundation (21YF5FA119).